Pharmaceutical Industry Information Portal


All posts by tag


FDA approves Sanofi’s Dupixent for widespread use in the United States

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said...

BioNTech and Regeneron strategic collaboration to advance FixVac and Libtayo® combination in NSCLC

BioNTech announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo® (cemiplimab), a PD-1...

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential...

COVID-19 dual-antibody therapies prevent emergence of drug resistance

Administration of antibody therapies bypasses the body’s slower and sometimes less effective process of making its own antibodies.

Expert Articles